Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin RD Morin, NA Johnson, TM Severson, AJ Mungall, J An, R Goya, JE Paul, ... Nature genetics 42 (2), 181-185, 2010 | 1970 | 2010 |
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma RE Davis, VN Ngo, G Lenz, P Tolar, RM Young, PB Romesser, ... Nature 463 (7277), 88-92, 2010 | 1902 | 2010 |
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma RD Morin, M Mendez-Lago, AJ Mungall, R Goya, KL Mungall, RD Corbett, ... Nature 476 (7360), 298-303, 2011 | 1881 | 2011 |
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone NA Johnson, GW Slack, KJ Savage, JM Connors, S Ben-Neriah, S Rogic, ... Journal of clinical oncology 30 (28), 3452, 2012 | 1106 | 2012 |
Phase II study of the efficacy and safety of pembrolizumab for relapsed/refractory classic Hodgkin lymphoma R Chen, PL Zinzani, MA Fanale, P Armand, NA Johnson, P Brice, ... Journal of Clinical Oncology 35 (19), 2125-2132, 2017 | 1009 | 2017 |
MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy KJ Savage, NA Johnson, S Ben-Neriah, JM Connors, LH Sehn, P Farinha, ... Blood, The Journal of the American Society of Hematology 114 (17), 3533-3537, 2009 | 797 | 2009 |
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival NA Johnson, KJ Savage, O Ludkovski, S Ben-Neriah, R Woods, C Steidl, ... Blood, The Journal of the American Society of Hematology 114 (11), 2273-2279, 2009 | 729 | 2009 |
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ... Nature 471 (7338), 377-381, 2011 | 697 | 2011 |
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing RD Morin, K Mungall, E Pleasance, AJ Mungall, R Goya, RD Huff, ... Blood, The Journal of the American Society of Hematology 122 (7), 1256-1265, 2013 | 461 | 2013 |
EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis I Velichutina, R Shaknovich, H Geng, NA Johnson, RD Gascoyne, ... Blood, The Journal of the American Society of Hematology 116 (24), 5247-5255, 2010 | 375 | 2010 |
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087 R Chen, PL Zinzani, HJ Lee, P Armand, NA Johnson, P Brice, J Radford, ... Blood, The Journal of the American Society of Hematology 134 (14), 1144-1153, 2019 | 308 | 2019 |
Systemic cancer therapy: achievements and challenges that lie ahead MO Palumbo, P Kavan, WH Miller Jr, L Panasci, S Assouline, N Johnson, ... Frontiers in pharmacology 4, 57, 2013 | 295 | 2013 |
Histological transformation and progression in follicular lymphoma: a clonal evolution study R Kridel, FC Chan, A Mottok, M Boyle, P Farinha, K Tan, B Meissner, ... PLoS medicine 13 (12), e1002197, 2016 | 235 | 2016 |
Genetic landscapes of relapsed and refractory diffuse large B-cell lymphomas RD Morin, S Assouline, M Alcaide, A Mohajeri, RL Johnston, L Chong, ... Clinical cancer research 22 (9), 2290-2300, 2016 | 228 | 2016 |
Prognostic factors in follicular lymphoma T Relander, NA Johnson, P Farinha, JM Connors, LH Sehn, ... J Clin Oncol 28 (17), 2902-2913, 2010 | 217 | 2010 |
BCL2 predicts survival in germinal center B-cell–like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab J Iqbal, PN Meyer, LM Smith, NA Johnson, JM Vose, TC Greiner, ... Clinical Cancer Research 17 (24), 7785-7795, 2011 | 214 | 2011 |
Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis KJJ Cheung, NA Johnson, JG Affleck, T Severson, C Steidl, S Ben-Neriah, ... Cancer research 70 (22), 9166-9174, 2010 | 211 | 2010 |
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL KJ Savage, GW Slack, A Mottok, LH Sehn, D Villa, R Kansara, R Kridel, ... Blood, The Journal of the American Society of Hematology 127 (18), 2182-2188, 2016 | 199 | 2016 |
Alemtuzumab for immune-related myocarditis due to PD-1 therapy K Esfahani, N Buhlaiga, P Thébault, R Lapointe, NA Johnson, ... New England Journal of Medicine 380 (24), 2375-2376, 2019 | 196 | 2019 |
BCL2 mutations in diffuse large B-cell lymphoma JM Schuetz, NA Johnson, RD Morin, DW Scott, K Tan, S Ben-Nierah, ... Leukemia 26 (6), 1383-1390, 2012 | 190 | 2012 |